1. Classification of Parkinson's disease from smartphone recording data using time-frequency analysis and convolutional neural network.
- Author
-
Worasawate, Denchai, Asawaponwiput, Warisara, Yoshimura, Natsue, Intarapanich, Apichart, and Surangsrirat, Decho
- Subjects
- *
CONVOLUTIONAL neural networks , *PARKINSON'S disease , *TIME-frequency analysis , *DATA recorders & recording , *CENTRAL nervous system diseases , *SUBTHALAMIC nucleus , *VOCAL cords - Abstract
BACKGROUND: Parkinson's disease (PD) is a long-term neurodegenerative disease of the central nervous system. The current diagnosis is dependent on clinical observation and the abilities and experience of a trained specialist. One of the symptoms that affects most patients is voice impairment. OBJECTIVE: Voice samples are non-invasive data that can be collected remotely for diagnosis and disease progression monitoring. In this study, we analyzed voice recording data from a smartphone as a possible medical self-diagnosis tool by using only one-second voice recording. The data from one of the largest mobile PD studies, the mPower study, was used. METHODS: A total of 29,798 ten-second voice recordings on smartphone from 4,051 participants were used for the analysis. The voice recordings were from sustained phonation by participants saying /aa/ for ten seconds into an iPhone microphone. A dataset comprising 385,143 short one-second audio samples was generated from the original ten-second voice recordings. The samples were converted to a spectrogram using a short-time Fourier transform. CNN models were then applied to classify the samples. RESULTS: Classification accuracies of the proposed method with LeNet-5, ResNet-50, and VGGNet-16 are 97.7 ± 0.1%, 98.6 ± 0.2%, and 99.3 ± 0.1%, respectively. CONCLUSIONS: We achieve a respectable classification performance using a generalized approach on a dataset with a large number of samples. The result emphasizes that an analysis based on one-second clip recorded on a smartphone could be a promising non-invasive and remotely available PD biomarker. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF